Financial statements Profarm 2000
Balance sheet data of PROFARM 2000
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 2 618 480,35 | 2 993 080,94 | 3 061 570,36 |
| A. Fixed assets | 136 715,36 | 199 877,06 | 190 919,00 |
| B. Current assets | 2 481 764,99 | 2 793 203,88 | 2 870 651,36 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 618 480,35 | 2 993 080,94 | 3 061 570,36 |
| A. Equity | 60 513,52 | 50 846,21 | -245 590,29 |
| B. Liabilities and provisions for liabilities | 2 557 966,83 | 2 942 234,73 | 3 307 160,65 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 2 492 250,65 | 2 817 232,12 | 3 150 603,33 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.